178 related articles for article (PubMed ID: 32795504)
1. Structure-functional implications of longevity protein p66Shc in health and disease.
Mir HA; Ali R; Mushtaq U; Khanday FA
Ageing Res Rev; 2020 Nov; 63():101139. PubMed ID: 32795504
[TBL] [Abstract][Full Text] [Related]
2. p66Shc as a switch in bringing about contrasting responses in cell growth: implications on cell proliferation and apoptosis.
Bhat SS; Anand D; Khanday FA
Mol Cancer; 2015 Apr; 14():76. PubMed ID: 25890053
[TBL] [Abstract][Full Text] [Related]
3. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.
Migliaccio E; Mele S; Salcini AE; Pelicci G; Lai KM; Superti-Furga G; Pawson T; Di Fiore PP; Lanfrancone L; Pelicci PG
EMBO J; 1997 Feb; 16(4):706-16. PubMed ID: 9049300
[TBL] [Abstract][Full Text] [Related]
4. p66Shc in Cardiovascular Pathology.
Haslem L; Hays JM; Hays FA
Cells; 2022 Jun; 11(11):. PubMed ID: 35681549
[TBL] [Abstract][Full Text] [Related]
5. Non-canonical dynamic mechanisms of interaction between the p66Shc protein and Met receptor.
Landry M; Pomerleau V; Saucier C
Biochem J; 2016 Jun; 473(11):1617-27. PubMed ID: 27048591
[TBL] [Abstract][Full Text] [Related]
6. [P66shc action on resistance of colon carcinoma RKO cells to oxidative stress].
Galimov ER; Sidorenko AS; Tereshkova AV; Pletiushkina OIu; Cherniak BV; Chumakov PM
Mol Biol (Mosk); 2012; 46(1):139-46. PubMed ID: 22642111
[TBL] [Abstract][Full Text] [Related]
7. p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice.
Tomita K; Teratani T; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Nishiyama K; Mataki N; Irie R; Minamino T; Okada Y; Kurihara C; Ebinuma H; Saito H; Shimizu I; Yoshida Y; Hokari R; Sugiyama K; Hatsuse K; Yamamoto J; Kanai T; Miura S; Hibi T
J Hepatol; 2012 Oct; 57(4):837-43. PubMed ID: 22641095
[TBL] [Abstract][Full Text] [Related]
8. Src homolog and collagen homolog1 isoforms in acute and chronic liver injuries.
Ma H; Wang C; Liu X; Zhan M; Wei W; Niu J
Life Sci; 2021 May; 273():119302. PubMed ID: 33662427
[TBL] [Abstract][Full Text] [Related]
9. The p52 isoform of SHC1 is a key driver of breast cancer initiation.
Wright KD; Miller BS; El-Meanawy S; Tsaih SW; Banerjee A; Geurts AM; Sheinin Y; Sun Y; Kalyanaraman B; Rui H; Flister MJ; Sorokin A
Breast Cancer Res; 2019 Jun; 21(1):74. PubMed ID: 31202267
[TBL] [Abstract][Full Text] [Related]
10. p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis.
Rajendran M; Thomes P; Zhang L; Veeramani S; Lin MF
Cancer Metastasis Rev; 2010 Mar; 29(1):207-22. PubMed ID: 20111892
[TBL] [Abstract][Full Text] [Related]
11. The interplay between p66Shc, reactive oxygen species and cancer cell metabolism.
Lebiedzinska-Arciszewska M; Oparka M; Vega-Naredo I; Karkucinska-Wieckowska A; Pinton P; Duszynski J; Wieckowski MR
Eur J Clin Invest; 2015 Jan; 45 Suppl 1():25-31. PubMed ID: 25524583
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells.
Veeramani S; Chou YW; Lin FC; Muniyan S; Lin FF; Kumar S; Xie Y; Lele SM; Tu Y; Lin MF
Free Radic Biol Med; 2012 Jul; 53(1):95-108. PubMed ID: 22561705
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and oxidative stress-related diseases: the p66Shc connection.
Pellegrini M; Baldari CT
Curr Mol Med; 2009 Apr; 9(3):392-8. PubMed ID: 19355920
[TBL] [Abstract][Full Text] [Related]
14. Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina.
Wu Z; Rogers B; Kachi S; Hackett SF; Sick A; Campochiaro PA
J Cell Physiol; 2006 Dec; 209(3):996-1005. PubMed ID: 16972253
[TBL] [Abstract][Full Text] [Related]
15. Role of adaptor protein p66Shc in renal pathologies.
Wright KD; Staruschenko A; Sorokin A
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F143-F153. PubMed ID: 28978535
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between SIRT1 and p66Shc in vascular diseases.
Chen HZ; Wan YZ; Liu DP
Trends Cardiovasc Med; 2013 Oct; 23(7):237-41. PubMed ID: 23499302
[TBL] [Abstract][Full Text] [Related]
17. P66shc and its role in ischemic cardiovascular diseases.
Boengler K; Bornbaum J; Schlüter KD; Schulz R
Basic Res Cardiol; 2019 Jun; 114(4):29. PubMed ID: 31165272
[TBL] [Abstract][Full Text] [Related]
18. The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter.
Ventura A; Luzi L; Pacini S; Baldari CT; Pelicci PG
J Biol Chem; 2002 Jun; 277(25):22370-6. PubMed ID: 11948181
[TBL] [Abstract][Full Text] [Related]
19. The mitochondrial reactive oxygen species regulator p66Shc controls PDGF-induced signaling and migration through protein tyrosine phosphatase oxidation.
Frijhoff J; Dagnell M; Augsten M; Beltrami E; Giorgio M; Östman A
Free Radic Biol Med; 2014 Mar; 68():268-77. PubMed ID: 24378437
[TBL] [Abstract][Full Text] [Related]
20. The p66shc adaptor protein controls oxidative stress response and life span in mammals.
Migliaccio E; Giorgio M; Mele S; Pelicci G; Reboldi P; Pandolfi PP; Lanfrancone L; Pelicci PG
Nature; 1999 Nov; 402(6759):309-13. PubMed ID: 10580504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
